SAP interacts with CD28 to inhibit PD-1 signaling in T lymphocytes is a research paper published in Clinical Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Cancer Research Institute
Grant: CA231277
Cancer Research Institute
Grant: AI25640
NIAID NIH HHS
Grant: R01 AI150597
NCI NIH HHS
Grant: R21 CA231277
NIAID NIH HHS
Grant: R01 AI125640
National Institutes of Health
Grant: 1R21CA231277-01A1
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
National Institutes of Health
Grant: 1R29AI025640-01A2
DEVELOPMENT OF TN916 INTO A MYCOPLASMA GENETIC TOOL
NIH
FWCI
0.72
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals